AXQ Capital
BBOT icon

AXQ Capital’s BridgeBio Oncology BBOT Stock Holding History

AXQ Capital’s Portfolio BBOT Stock Details BBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$217K Buy
53,001
+42,273
+394% +$328K 0.03% 723
2026
Q2 		$81.7K Sell
10,728
-6,619
-38% -$55.2K 0.01% 867
2026
Q1 		$155K Buy
+17,347
New +$186K 0.02% 803

Other funds holding BBOT

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Alphabet Inc
Alphabet Inc Mountain View, California $88.3B AUM 46.07% 1-Year Est. Return
Regents of the University of California
Regents of the University of California Oakland, California $6.64B AUM 23.46% 1-Year Est. Return
Laurion Capital Management
Laurion Capital Management New York $6.21B AUM 32.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Aisling Capital Management
Aisling Capital Management New York $299M AUM 39.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return

AXQ Capital's BBOT Position: Q3 2026 in Review

AXQ Capital increased its BridgeBio Oncology (BBOT) stake by 394% in Q3 2026, buying an estimated $328K and bringing the position to 53,001 shares worth $217K. The position accounts for 0.03% of the portfolio, ranked #723.

AXQ Capital first reported a position in BBOT in Q1 2026 and has held it in 3 quarters since. 44 funds tracked by Wall St. Rank hold BBOT as of Q3 2026.

  • AXQ Capital held 53,001 shares of BridgeBio Oncology worth $217K as of Q3 2026.
  • AXQ Capital bought 42,273 BridgeBio Oncology shares in Q3 2026, an estimated $328K.
  • BridgeBio Oncology made up 0.03% of AXQ Capital's portfolio in Q3 2026, its #723 holding.
  • AXQ Capital first reported a position in BridgeBio Oncology in Q1 2026 and has held it in 3 quarters since.
  • 44 funds tracked by Wall St. Rank held BridgeBio Oncology as of Q3 2026.

Based on AXQ Capital's 13F filing for Q3 2026, filed 12 Nov 2026.